Skip to main content

Advertisement

SpringerLink
Log in

Dopamine from cirrhotic liver contributes to the impaired learning and memory ability of hippocampus in minimal hepatic encephalopathy

  • Original Article
  • Published:
Hepatology International Aims and scope Submit manuscript

Abstract

Background Defective learning/memory ability is a feature of MHE. However, the exact pathophysiological mechanisms leading to the impairment of learning/memory ability in MHE remain not clearly understood. Methods MHE rat modeling by intraperitoneal injection of TAA was successfully established using a Morris water maze, BAEP, and EEG tests. COMT inhibitor, a protein involved in the accumulation of dopamine (DA), was found to be up-regulated in cirrhotic livers in MHE by 2-DE/MS. Results The levels of DA in cirrhotic livers, serums and hippocampuses in the MHE group were more significantly increased than in the control group. In the hippocampuses of MHE rats, NMDA-induced formation of cGMP was reduced by 40 % as determined by in vivo brain microdialysis. Activation of sGC by NO was reduced by 38 %. The expression of NMDAR1, CaM, nNOS and sGC in the hippocampus in the MHE group were more significantly decreased than in controls. Chronic exposure of cultured hippocampus neurons to DA (50 μM) reduced by 53 % the NMDA-induced formation of cGMP. Activation of sGC by NO in these neurons was reduced by 44 %. Down-regulated NMDAR1, CaM, nNOS and sGC were also detected in neurons treated with dopamine, in contrast with the controls. Conclusions This study suggests that when the glutamate-NO-cGMP pathway in the hippocampus is inhibited by the elevation of DA from cirrhotic livers, this in turn may lead to the impairment of learning and memory ability of MHE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Dhiman RK, Chawla YK. Minimal hepatic encephalopathy. Indian J Gastroenterol. 2009;28(1):5–16

    Article  PubMed  Google Scholar 

  2. Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology. 2007;45(3):549–559

    Article  PubMed  Google Scholar 

  3. Quero JC, Schalm SW. Subclinical hepatic encephalopathy. Semin Liver Dis. 1996;16(3):321–328

    Article  CAS  PubMed  Google Scholar 

  4. Romero-Gómez M, Boza F, García-Valdecasas MS, García E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol. 2001;96(9):2718–2723

    PubMed  Google Scholar 

  5. Groeneweg M, Quero JC, De Bruijn I, Hartmann IJ, Essink-bot ML, Hop WC, Schalm SW. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology. 1998;28(1):45–49

    Article  CAS  PubMed  Google Scholar 

  6. Tan HH, Lee GH, Thia KT, Ng HS, Chow WC, Lui HF. Minimal hepatic encephalopathy runs a fluctuating course: results from a three-year prospective cohort follow-up study. Singapore Med J. 2009;50(3):255–260

    CAS  PubMed  Google Scholar 

  7. Amodio P, Montagnese S, Gatta A, Morgan MY. Characteristics of minimal hepatic encephalopathy. Metab Brain Dis. 2004;19(3–4):253–267

    Article  PubMed  Google Scholar 

  8. Amodio P, Del Piccolo F, Marchetti P, Angeli P, Iemmolo R, Caregaro L, Merkel C, Gerunda G, Gatta A. Clinical features and survival of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology. 1999;29(6):1662–1667

    Article  CAS  PubMed  Google Scholar 

  9. Hartmann IJ, Groeneweg M, Quero JC, Beijeman SJ, de Man RA, Hop WC, Schalm SW. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol. 2000;95(8):2029–2034

    Article  CAS  PubMed  Google Scholar 

  10. Romero-Gómez M, Grande L, Camacho I. Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy. Hepatology. 2004;39(4):939–943

    Article  PubMed  Google Scholar 

  11. Butterworth RF. Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metab Brain Dis. 2002;17(4):221–227

    Article  CAS  PubMed  Google Scholar 

  12. Vaquero J, Chung C, Blei AT. Brain edema in acute liver failure. A window to the pathogenesis of hepatic encephalopathy. Ann Hepatol. 2003;2(1):12–22

    PubMed  Google Scholar 

  13. Rama Rao KV, Reddy PV, Hazell AS, Norenberg MD. Manganese induces cell swelling in cultured astrocytes. Neurotoxicology. 2007;28(4):807–812

    Article  CAS  PubMed  Google Scholar 

  14. Das K, Singh P, Chawla Y, Duseja A, Dhiman RK, Suri S. Magnetic resonance imaging of brain in patients with cirrhotic and non-cirrhotic portal hypertension. Dig Dis Sci. 2008;53(10):2793–2798

    Article  PubMed  Google Scholar 

  15. Shawcross DL, Wright G, Olde Damink SW, Jalan R. Role of ammonia and inflammation in minimal hepatic encephalopathy. Metab Brain Dis. 2007;22(1):125–138

    Article  CAS  PubMed  Google Scholar 

  16. Bernabeu R, Schmitz P, Faillace MP, Izquierdo I, Medina JH. Hippocampal cGMP and cAMP are differentially involved in memory processing of inhibitory avoidance learning. Neuroreport. 1996;7(2):585–588

    Article  CAS  PubMed  Google Scholar 

  17. Bernabeu R, Schroder N, Quevedo J, Cammarota M, Izquierdo I, Medina JH. Further evidence for the involvement of a hippocampal cGMP/cGMP-dependent protein kinase cascade in memory consolidation. Neuroreport. 1997;8(9–10):2221–2224

    Article  CAS  PubMed  Google Scholar 

  18. Yamada K, Hiramatsu M, Noda Y, Mamiya T, Murai M, Kameyama T, Komori Y, Nikai T, Sugihara H, Nabeshima T. Role of nitric oxide and cyclic GMP in the dizocilpine-induced impairment of spontaneous alternation behavior in mice. Neuroscience. 1996;74(2):365–374

    Article  CAS  PubMed  Google Scholar 

  19. Weissenborn K, Heidenreich S, Giewekemeyer K, Rückert N, Hecker H. Memory function in early hepatic encephalopathy. J Hepatol. 2003;39(3):320–325

    Article  PubMed  Google Scholar 

  20. Monfort P, Corbalán R, Martinez L, López-Talavera J, Córdoba J, Felipo V. Altered content and modulation of soluble guanylate cyclase in the cerebellum of rats with portacaval anastomosis. Neuroscience. 2001;104(4):1119–1125

    Article  CAS  PubMed  Google Scholar 

  21. Erceg S, Monfort P, Hernández-Viadel M, Rodrigo R, Montoliu C, Felipo V. Oral administration of sildenafil restores learning ability in rats with hyperammonemia and with portacaval shunts. Hepatology. 2005;41(2):299–306

    Article  CAS  PubMed  Google Scholar 

  22. Simpson GV, Knight RT, Brailowsky S, Prospero-Garcia O, Scabini D. Altered peripheral and brainstem auditory function in aged rats. Brain Res. 1985;348(1):28–35

    Article  CAS  PubMed  Google Scholar 

  23. Li C, Xiao Z, Chen Z, Zhang X, Li J, Wu X, Li X, Yi H, Li M, Zhu G, Liang S. Proteome analysis of human lung squamous carcinoma. Proteomics. 2006;6(2):547–558

    Article  CAS  PubMed  Google Scholar 

  24. Li C, Wang W, Wang H, Zhong Y, Di J, Lin Y. Proteomic analysis of proteins differentially expressed in uterine lymphocytes obtained from wild-type and NOD mice. J Cell Biochem. 2009;108(2):447–457

    Article  CAS  PubMed  Google Scholar 

  25. Colado MI, Ormazabal MJ, Alfaro MJ, Martin MI. Effect of Bay K 8644 on the synthesis and metabolism of dopamine and 5-hydroxytryptamine in various brain areas of the rat. J Pharm Pharmacol. 1993;45(3):220–222

    Article  CAS  PubMed  Google Scholar 

  26. Yi Z, Petralia RS, Fu Z, Swanwick CC, Wang YX, Prybylowski K, Sans N, Vicini S, Wenthold RJ. The role of the PDZ protein GIPC in regulating NMDA receptor trafficking. J Neurosci. 2007;27(43):11663–11675

    Article  CAS  PubMed  Google Scholar 

  27. Marini AM, Paul SM. N-Methyl-d-aspartate receptor-mediated neuroprotection in cerebellar granule cells requires new RNA and protein synthesis. Proc Natl Acad Sci USA. 1992;89(14):6555–6559

    Article  CAS  PubMed  Google Scholar 

  28. Morris RG, Garrud P, Rawlins JN, O’Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature. 1982;297(5868):681–683

    Article  CAS  PubMed  Google Scholar 

  29. Morris RG, Hagan JJ, Rawlins JN. Allocentric spatial learning by hippocampectomised rats: a further test of the “spatial mapping” and “working memory” theories of hippocampal function. Q J Exp Psychol B. 1986;38(4):365–395

    CAS  PubMed  Google Scholar 

  30. Packard MG, Teather LA. Posttraining injections of MK-801 produce a time-dependent impairment of memory in two water maze tasks. Neurobiol Learn Mem. 1997;68(1):42–50

    Article  CAS  PubMed  Google Scholar 

  31. D’Hooge R, De Deyn PP. Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev. 2001;36(1):60–90

    Article  PubMed  Google Scholar 

  32. Mehndiratta MM, Sood GK, Sarin SK, Gupta M. Comparative evaluation of visual, somatosensory, and auditory evoked potentials in the detection of subclinical hepatic encephalopathy in patients with nonalcoholic cirrhosis. Am J Gastroenterol. 1990;85(7):799–803

    CAS  PubMed  Google Scholar 

  33. Boulton CL, Southam E, Garthwaite J. Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase. Neuroscience. 1995;69(3):699–703

    Article  CAS  PubMed  Google Scholar 

  34. Hawkins RD, Son H, Arancio O. Nitric oxide as a retrograde messenger during long-term potentiation in hippocampus. Prog Brain Res. 1998;118:155–172

    Article  CAS  PubMed  Google Scholar 

  35. Chen J, Zhang S, Zuo P, Tang L. Memory-related changes of nitric oxide synthase activity and nitrite level in rat brain. Neuroreport. 1997;8(7):1771–1774

    Article  CAS  PubMed  Google Scholar 

  36. Danysz W, Zajaczkowski W, Parsons CG. Modulation of learning processes by ionotropic glutamate receptor ligands. Behav Pharmacol. 1995;6(5 And 6):455–474

    CAS  PubMed  Google Scholar 

  37. Ingram DK, Spangler EL, Kametani H, Meyer RC, London ED. Intracerebroventricular injection of N-omega-nitro-l-arginine in rats impairs learning in a 14-unit T-maze. Eur J Pharmacol. 1998;341(1):11–16

    Article  CAS  PubMed  Google Scholar 

  38. Meyer RC, Knox J, Purwin DA, Spangler EL, Ingram DK. Combined stimulation of the glycine and polyamine sites of the NMDA receptor attenuates NMDA blockade-induced learning deficits of rats in a 14-unit T-maze. Psychopharmacology. 1998;135(3):290–295

    Article  CAS  PubMed  Google Scholar 

  39. Prickaerts J, Steinbusch HW, Smits JF, de Vente J. Possible role of nitric oxide-cyclic GMP pathway in object recognition memory: effects of 7-nitroindazole and zaprinast. Eur J Pharmacol. 1997;337(2–3):125–136

    Article  CAS  PubMed  Google Scholar 

  40. Zou LB, Yamada K, Nabeshima T. Sigma receptor ligands (+)-SKF10,047 and SA4503 improve dizocilpine-induced spatial memory deficits in rats. Eur J Pharmacol. 1998;355(1):1–10

    Article  CAS  PubMed  Google Scholar 

  41. Córdoba J, Cabrera J, Lataif L, Penev P, Zee P, Blei AT. High prevalence of sleep disturbance in cirrhosis. Hepatology. 1998;27(2):339–345

    Article  PubMed  Google Scholar 

  42. Garfinkel D, Zisapel N. Liver cirrhosis and circadian rhythm. Ann Intern Med. 1996;125(2):154

    Article  CAS  PubMed  Google Scholar 

  43. O’Carroll RE, Hayes PC, Ebmeier KP, Dougall N, Murray C, Best JJ, Bouchier IA, Goodwin GM. Regional cerebral blood flow and cognitive function in patients with chronic liver disease. Lancet. 1991;337(8752):1250–1253

    Article  PubMed  Google Scholar 

  44. Pantiga C, Rodrigo LR, Cuesta M, Lopez L, Arias JL. Cognitive deficits in patients with hepatic cirrhosis and in liver transplant recipients. J Neuropsychiatry Clin Neurosci. 2003;15(1):84–89

    Article  PubMed  Google Scholar 

  45. Hermenegildo C, Montoliu C, Llansola M, Muñoz MD, Gaztelu JM, Miñana MD, Felipo V. Chronic hyperammonemia impairs the glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in the rat in vivo. Eur J Neurosci. 1998;10(10):3201–3209

    Article  CAS  PubMed  Google Scholar 

  46. Corbalán R, Chatauret N, Behrends S, Butterworth RF, Felipo V. Region selective alterations of soluble guanylate cyclase content and modulation in brain of cirrhotic patients. Hepatology. 2002;36(5):1155–1162

    Article  PubMed  Google Scholar 

  47. Moustafa AA, Herzallah MM, Gluck MA. Dissociating the cognitive effects of levodopa versus dopamine agonists in a neurocomputational model of learning in Parkinson’s disease. Neurodegener Dis. 2012;31:102–111

    Google Scholar 

  48. Castro NG, de Mello MC, de Mello FG, Aracava Y. Direct inhibition of the N-methyl-d-aspartate receptor channel by dopamine and (+)-SKF38393. Br J Pharmacol. 1999;126(8):1847–1855

    Article  CAS  PubMed  Google Scholar 

  49. Zheng P, Zhang XX, Bunney BS, Shi WX. Opposite modulation of cortical N-methyl-d-aspartate receptor-mediated responses by low and high concentrations of dopamine. Neuroscience. 1999;91(2):527–535

    Article  CAS  PubMed  Google Scholar 

  50. Seamans JK, Yang CR. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol. 2004;74(1):1–58

    Article  CAS  PubMed  Google Scholar 

  51. Cui C, Xu M, Atzor M. Voltage-dependent block of N-methyl-d-aspartate receptors by dopamine D1 receptor ligands. Mol Pharmacol. 2006;70(5):61–1770

    Article  Google Scholar 

  52. Altar CA, Boyar WC, Kim HS. Discriminatory roles for D1 and D2 dopamine receptor subtypes in the in vivo control of neostriatal cyclic GMP. Eur J Pharmacol. 1990;181(1–2):17–21

    Article  CAS  PubMed  Google Scholar 

  53. Di Stefano A, Sozio P, Cacciatore I, Cocco A, Giorgioni G, Costa B, Montali M, Lucacchini A, Martini C, Spoto G, Di Pietrantonio F, Di Matteo E, Pinnen F. Preparation and pharmacological characterization of trans-2-amino-5(6)-fluoro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as D2-like dopamine receptor agonists. J Med Chem. 2005;48(7):2646–2654

    Article  PubMed  Google Scholar 

  54. Hoque KE, Indorkar RP, Sammut S, West AR. Impact of dopamine-glutamate interactions on striatal neuronal nitric oxide synthase activity. Psychopharmacology. 2010;207(4):571–581

    Article  CAS  PubMed  Google Scholar 

  55. Park DJ, West AR. Regulation of striatal nitric oxide synthesis by local dopamine and glutamate interactions. J Neurochem. 2009;111(6):1457–1465

    Article  CAS  PubMed  Google Scholar 

  56. Sammut S, Dec A, Mitchell D, Linardakis J, Ortiguela M, West AR. Phasic dopaminergic transmission increases NO efflux in the rat dorsal striatum via a neuronal NOS and a dopamine D(1/5) receptor-dependent mechanism. Neuropsychopharmacology. 2006;31(3):493–505

    Article  CAS  PubMed  Google Scholar 

  57. Siuciak JA, McCarthy SA, Chapin DS, Fujiwara RA, James LC, Williams RD, Stock JL, McNeish JD, Strick CA, Menniti FS, Schmidt CJ. Genetic deletion of the striatum-enriched phosphodiesterase PDE10A: evidence for altered striatal function. Neuropharmacology. 2006;51(2):374–385

    Article  CAS  PubMed  Google Scholar 

  58. Calabresi P, Centonze D, Gubellini P, Marfia GA, Pisani A, Sancesario G, Bernardi G. Synaptic transmission in the striatum: from plasticity to neurodegeneration. Prog Neurobiol. 2000;61(3):231–265

    Article  CAS  PubMed  Google Scholar 

  59. Centonze D, Gubellini P, Pisani A, Bernardi G, Calabresi P. Dopamine, acetylcholine and nitric oxide systems interact to induce corticostriatal synaptic plasticity. Rev Neurosci. 2003;14(3):207–216

    CAS  PubMed  Google Scholar 

  60. Kawaguchi Y. Neostriatal cell subtypes and their functional roles. Neurosci Res. 1997;27(1):1–8

    Article  CAS  PubMed  Google Scholar 

  61. West AR, Grace AA. Opposite influences of endogenous dopamine D1 and D2 receptor activation on activity states and electrophysiological properties of striatal neurons: studies combining in vivo intracellular recordings and reverse microdialysis. J Neurosci. 2002;22(1):294–304

    CAS  PubMed  Google Scholar 

  62. Galati S, D’angelo V, Scarnati E, Stanzione P, Martorana A, Procopio T, Sancesario G, Stefani A. In vivo electrophysiology of dopamine-denervated striatum: focus on the nitric oxide/cGMP signaling pathway. Synapse. 2008;62(6):409–420

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This study was funded by science and technology plan projects of Wenzhou city (Y20110155).

Author information

Authors and Affiliations

  1. Wenzhou Key Laboratory of Surgery, The First Affiliated Hospital of Wenzhou Medical College, Wenzhou, 325000, China

    Saidan Ding, Leping Liu, Jieya Xie & Bicheng Chen

  2. Neurosurgery Department, The First Affiliated Hospital of Wenzhou Medical College, Wenzhou, 325000, China

    Huajun Jing, Xiaobin Wang, Jinpeng Mao & Qichuan Zhuge

Authors
  1. Saidan Ding
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leping Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Huajun Jing
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jieya Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiaobin Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jinpeng Mao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Bicheng Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Qichuan Zhuge
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Qichuan Zhuge.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ding, S., Liu, L., Jing, H. et al. Dopamine from cirrhotic liver contributes to the impaired learning and memory ability of hippocampus in minimal hepatic encephalopathy. Hepatol Int 7, 923–936 (2013). https://doi.org/10.1007/s12072-013-9431-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12072-013-9431-6

Keywords

Search

Navigation